Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis

IntroductionIn sarcoidosis, peripheral lymphopenia and anergy have been associated with increased inflammation and maladaptive immune activity, likely promoting development of chronic and progressive disease. However, the molecular mechanisms that lead to reduced lymphocyte proportions, particularly...

Full description

Bibliographic Details
Main Authors: Christian Ascoli, Cody A. Schott, Yue Huang, Benjamin A. Turturice, Wangfei Wang, Naomi Ecanow, Nadera J. Sweiss, David L. Perkins, Patricia W. Finn
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.848759/full
_version_ 1811240593267884032
author Christian Ascoli
Cody A. Schott
Yue Huang
Benjamin A. Turturice
Wangfei Wang
Naomi Ecanow
Nadera J. Sweiss
Nadera J. Sweiss
David L. Perkins
Patricia W. Finn
author_facet Christian Ascoli
Cody A. Schott
Yue Huang
Benjamin A. Turturice
Wangfei Wang
Naomi Ecanow
Nadera J. Sweiss
Nadera J. Sweiss
David L. Perkins
Patricia W. Finn
author_sort Christian Ascoli
collection DOAJ
description IntroductionIn sarcoidosis, peripheral lymphopenia and anergy have been associated with increased inflammation and maladaptive immune activity, likely promoting development of chronic and progressive disease. However, the molecular mechanisms that lead to reduced lymphocyte proportions, particularly CD4+ T-cells, have not been fully elucidated. We posit that paradoxical peripheral lymphopenia is characterized by a dysregulated transcriptomic network associated with cell function and fate that results from altered transcription factor targeting activity.MethodsMessenger RNA-sequencing (mRNA-seq) was performed on peripheral blood mononuclear cells (PBMCs) from ACCESS study subjects with sarcoidosis and matched controls and findings validated on a sarcoidosis case-control cohort and a sarcoidosis case series. Preserved PBMC transcriptomic networks between case-control cohorts were assessed to establish cellular associations with gene modules and define regulatory targeting involved in sarcoidosis immune dysregulation utilizing weighted gene co-expression network analysis and differential transcription factor involvement analysis. Network centrality measures identified master transcriptional regulators of subnetworks related to cell proliferation and death. Predictive models of differential PBMC proportions constructed from ACCESS target gene expression corroborated the relationship between aberrant transcription factor regulatory activity and imputed and clinical PBMC populations in the validation cohorts.ResultsWe identified two unique and preserved gene modules significantly associated with sarcoidosis immune dysregulation. Strikingly, increased expression of a monocyte-driven, and not a lymphocyte-driven, gene module related to innate immunity and cell death was the best predictor of peripheral CD4+ T-cell proportions. Within the gene network of this monocyte-driven module, TLE3 and CBX8 were determined to be master regulators of the cell death subnetwork. A core gene signature of differentially over-expressed target genes of TLE3 and CBX8 involved in cellular communication and immune response regulation accurately predicted imputed and clinical monocyte expansion and CD4+ T-cell depletion.ConclusionsAltered transcriptional regulation associated with aberrant gene expression of a monocyte-driven transcriptional network likely influences lymphocyte function and survival. Although further investigation is warranted, this indicates that crosstalk between hyperactive monocytes and lymphocytes may instigate peripheral lymphopenia and underlie sarcoidosis immune dysregulation and pathogenesis. Future therapies selectively targeting master regulators, or their targets, may mitigate dysregulated immune processes in sarcoidosis and disease progression.
first_indexed 2024-04-12T13:22:57Z
format Article
id doaj.art-5b1cf0d57fea42a1aa3ffbe103ee6255
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T13:22:57Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-5b1cf0d57fea42a1aa3ffbe103ee62552022-12-22T03:31:25ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.848759848759Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosisChristian Ascoli0Cody A. Schott1Yue Huang2Benjamin A. Turturice3Wangfei Wang4Naomi Ecanow5Nadera J. Sweiss6Nadera J. Sweiss7David L. Perkins8Patricia W. Finn9Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United StatesUniversity of Illinois at Chicago College of Medicine, Chicago, IL, United StatesDivision of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United StatesUniversity of Illinois at Chicago College of Medicine, Chicago, IL, United StatesDepartment of Bioengineering, University of Illinois at Chicago College of Engineering and Medicine, Chicago, IL, United StatesUniversity of Illinois at Chicago College of Medicine, Chicago, IL, United StatesDivision of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United StatesDivision of Rheumatology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United StatesDivision of Nephrology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United StatesDivision of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United StatesIntroductionIn sarcoidosis, peripheral lymphopenia and anergy have been associated with increased inflammation and maladaptive immune activity, likely promoting development of chronic and progressive disease. However, the molecular mechanisms that lead to reduced lymphocyte proportions, particularly CD4+ T-cells, have not been fully elucidated. We posit that paradoxical peripheral lymphopenia is characterized by a dysregulated transcriptomic network associated with cell function and fate that results from altered transcription factor targeting activity.MethodsMessenger RNA-sequencing (mRNA-seq) was performed on peripheral blood mononuclear cells (PBMCs) from ACCESS study subjects with sarcoidosis and matched controls and findings validated on a sarcoidosis case-control cohort and a sarcoidosis case series. Preserved PBMC transcriptomic networks between case-control cohorts were assessed to establish cellular associations with gene modules and define regulatory targeting involved in sarcoidosis immune dysregulation utilizing weighted gene co-expression network analysis and differential transcription factor involvement analysis. Network centrality measures identified master transcriptional regulators of subnetworks related to cell proliferation and death. Predictive models of differential PBMC proportions constructed from ACCESS target gene expression corroborated the relationship between aberrant transcription factor regulatory activity and imputed and clinical PBMC populations in the validation cohorts.ResultsWe identified two unique and preserved gene modules significantly associated with sarcoidosis immune dysregulation. Strikingly, increased expression of a monocyte-driven, and not a lymphocyte-driven, gene module related to innate immunity and cell death was the best predictor of peripheral CD4+ T-cell proportions. Within the gene network of this monocyte-driven module, TLE3 and CBX8 were determined to be master regulators of the cell death subnetwork. A core gene signature of differentially over-expressed target genes of TLE3 and CBX8 involved in cellular communication and immune response regulation accurately predicted imputed and clinical monocyte expansion and CD4+ T-cell depletion.ConclusionsAltered transcriptional regulation associated with aberrant gene expression of a monocyte-driven transcriptional network likely influences lymphocyte function and survival. Although further investigation is warranted, this indicates that crosstalk between hyperactive monocytes and lymphocytes may instigate peripheral lymphopenia and underlie sarcoidosis immune dysregulation and pathogenesis. Future therapies selectively targeting master regulators, or their targets, may mitigate dysregulated immune processes in sarcoidosis and disease progression.https://www.frontiersin.org/articles/10.3389/fimmu.2022.848759/fullsarcoidosistranscriptomicsimmune dysregulationmaster regulatorsPBMC
spellingShingle Christian Ascoli
Cody A. Schott
Yue Huang
Benjamin A. Turturice
Wangfei Wang
Naomi Ecanow
Nadera J. Sweiss
Nadera J. Sweiss
David L. Perkins
Patricia W. Finn
Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
Frontiers in Immunology
sarcoidosis
transcriptomics
immune dysregulation
master regulators
PBMC
title Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
title_full Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
title_fullStr Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
title_full_unstemmed Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
title_short Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
title_sort altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
topic sarcoidosis
transcriptomics
immune dysregulation
master regulators
PBMC
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.848759/full
work_keys_str_mv AT christianascoli alteredtranscriptionfactortargetingisassociatedwithdifferentialperipheralbloodmononuclearcellproportionsinsarcoidosis
AT codyaschott alteredtranscriptionfactortargetingisassociatedwithdifferentialperipheralbloodmononuclearcellproportionsinsarcoidosis
AT yuehuang alteredtranscriptionfactortargetingisassociatedwithdifferentialperipheralbloodmononuclearcellproportionsinsarcoidosis
AT benjaminaturturice alteredtranscriptionfactortargetingisassociatedwithdifferentialperipheralbloodmononuclearcellproportionsinsarcoidosis
AT wangfeiwang alteredtranscriptionfactortargetingisassociatedwithdifferentialperipheralbloodmononuclearcellproportionsinsarcoidosis
AT naomiecanow alteredtranscriptionfactortargetingisassociatedwithdifferentialperipheralbloodmononuclearcellproportionsinsarcoidosis
AT naderajsweiss alteredtranscriptionfactortargetingisassociatedwithdifferentialperipheralbloodmononuclearcellproportionsinsarcoidosis
AT naderajsweiss alteredtranscriptionfactortargetingisassociatedwithdifferentialperipheralbloodmononuclearcellproportionsinsarcoidosis
AT davidlperkins alteredtranscriptionfactortargetingisassociatedwithdifferentialperipheralbloodmononuclearcellproportionsinsarcoidosis
AT patriciawfinn alteredtranscriptionfactortargetingisassociatedwithdifferentialperipheralbloodmononuclearcellproportionsinsarcoidosis